A systematic review of the psychosocial impact of fibroids before and after treatment

American Journal of Obstetrics and Gynecology - Tập 223 - Trang 674-708.e8 - 2020
Virginia Arlene A. Go1, Martha C. Thomas2, Bhuchitra Singh3, Sarah Prenatt3, Holly Sims3, Jaime F. Blanck3, James H. Segars3
1Department of Obstetrics and Gynecology, Saint Joseph Hospital, Denver, CO
2Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, MS
3Division of Reproductive Science and Women’s Health Research, Department of Gynecology and Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, MD

Tài liệu tham khảo

Baird, 2003, High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence, Am J Obstet Gynecol, 188, 100, 10.1067/mob.2003.99 Drayer, 2015, Prevalence, morbidity, and current medical management of uterine leiomyomas, Int J Gynecol Obstet, 131, 117, 10.1016/j.ijgo.2015.04.051 Whiteman, 2008, Inpatient hysterectomy surveillance in the United States, 2000–2004, Am J Obstet Gynecol, 198, 34.e1, 10.1016/j.ajog.2007.05.039 Cardozo, 2012, The estimated annual cost of uterine leiomyomata in the United States, Am J Obstet Gynecol, 206, 211.e1, 10.1016/j.ajog.2011.12.002 Mauskopf, 2005, The economic impact of uterine fibroids in the United States: a summary of published estimates, J Womens Health (Larchmt), 14, 692, 10.1089/jwh.2005.14.692 Borah, 2013, The impact of uterine leiomyomas: a national survey of affected women, Am J Obstet Gynecol, 209, 319.e1, 10.1016/j.ajog.2013.07.017 Pron, 2003, The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life, Fertil Steril, 79, 112, 10.1016/S0015-0282(02)04539-9 Pritts, 2001, Fibroids and infertility: a systematic review of the evidence, Obstet Gynecol Surv, 56, 483, 10.1097/00006254-200108000-00022 Gupta, 2008, Clinical presentation of fibroids, Best Pract Res Clin Obstet Gynaecol, 22, 615, 10.1016/j.bpobgyn.2008.01.008 Downes, 2010, The burden of uterine fibroids in five European countries, Eur J Obstet Gynecol Reprod Biol, 152, 96.e102, 10.1016/j.ejogrb.2010.05.012 Al-Hendy, 2017, Uterine fibroids: burden and unmet medical need, Semin Reprod Med, 35, 473, 10.1055/s-0037-1607264 Barlow, 2011, 220 Women with uterine fibroids have high levels of pain and substantially impaired quality of life (qol), Hum Reprod, 26, i208 Nicholls, 2004, The illness experiences of women with fibroids: an exploratory qualitative study, J Psychosom Obstet Gynecol, 25, 295, 10.1080/01674820400024430 Spies, 2002, The UFS-QoL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata, Obstet Gynecol, 99, 290 Stewart, 2013, The burden of uterine fibroids for African-American women: results of a national survey, J Womens Health (Larchmt), 22, 807, 10.1089/jwh.2013.4334 Lee, 2007, The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids, J Occup Environ Med, 49, 493, 10.1097/JOM.0b013e31805f6cf2 Ghant, 2014, Beyond the physical: a qualitative assessment of the emotional burden of symptomatic uterine fibroids on women’s mental health, Fertil Steril, 102, e248, 10.1016/j.fertnstert.2014.07.844 Soliman, 2017, Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey, Curr Med Res Opin, 33, 1971, 10.1080/03007995.2017.1372107 Higgins, 2011, The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, 10.1136/bmj.d5928 Wells Wang, 2013, Effect of high-intensity focused ultrasound on sexual function in the treatment of uterine fibroids: comparison to conventional myomectomy, Arch Gynecol Obstet, 288, 851, 10.1007/s00404-013-2775-2 Rattray, 2018, Clinical outcomes and health care utilization pre-and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada, Clinicoecon Outcomes Res, 10, 201, 10.2147/CEOR.S155038 Jacoby, 2016, PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids, Fertil Steril, 105, 773, 10.1016/j.fertnstert.2015.11.014 Krämer, 2016, Interim analysis of a randomized controlled trial comparing laparoscopic radiofrequency volumetric thermal ablation of uterine fibroids with laparoscopic myomectomy, Int J Gynecol Obstet, 133, 206, 10.1016/j.ijgo.2015.10.008 Laughlin-Tommaso, 2020, Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF fibroid registry, Am J Obstet Gynecol, 222, 345.e1, 10.1016/j.ajog.2019.09.052 Hehenkamp, 2008, Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy—results from the randomized clinical Embolisation versus Hysterectomy (EMMY) Trial, Radiology, 246, 823, 10.1148/radiol.2463070260 Hehenkamp, 2007, Sexuality and body image after uterine artery embolization and hysterectomy in the treatment of uterine fibroids: a randomized comparison, Cardiovasc Interv Rad, 30, 866, 10.1007/s00270-007-9121-7 De Bruijn, 2016, Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 10 years’ outcomes from the randomized EMMY trial, Obstet Gynecol Surv, 71, 653, 10.1097/01.ogx.0000503331.67536.b9 Shlansky-Goldberg, 2014, Comparison of polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine fibroid embolization: results of a single-center randomized study, J Vasc Interv Radiol, 25, 823, 10.1016/j.jvir.2014.03.009 Yadavali, 2019, Randomised trial of two embolic agents for uterine artery embolisation for fibroids: gelfoam versus embospheres (RAGE trial), CVIR Endovas, 2, 10.1186/s42155-018-0044-y Fiscella, 2006, Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial, Obstet Gynecol, 108, 1381, 10.1097/01.AOG.0000243776.23391.7b Carr, 2018, Elagolix alone or with add-back therapy in women with heavy menstrual bleeding and uterine leiomyomas: a randomized controlled trial, Obstet Gynecol, 132, 1252, 10.1097/AOG.0000000000002933 Osuga, 2019, Oral gonadotropin-releasing hormone antagonist relugolix compared with leuprorelin injections for uterine leiomyomas: a randomized controlled trial, Obstet Gynecol, 133, 423, 10.1097/AOG.0000000000003141 Liu, 2018, Ulipristal acetate for treatment of uterine leiomyomas: a randomized controlled trial, Obstet Gynecol, 132, 1241, 10.1097/AOG.0000000000002942 Lukes, 2019, Health-related quality of life with ulipristal acetate for treatment of uterine leiomyomas: a randomized controlled trial, Obstet Gynecol, 133, 869, 10.1097/AOG.0000000000003211 Levens, 2008, CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial, Obstet Gynecol, 111, 1129, 10.1097/AOG.0b013e3181705d0e Simon, 2018, Ulipristal acetate for treatment of symptomatic uterine leiomyomas: a randomized controlled trial, Obstet Gynecol, 131, 431, 10.1097/AOG.0000000000002462 Stewart, 2019, Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials, Hum Reprod, 34, 623, 10.1093/humrep/dez007 Takmaz, 2018, Symptoms and health quality after laparoscopic and robotic myomectomy, JSLS, 22, 10.4293/JSLS.2018.00030 Tsuzuki, 2019, Recovery of quality of life after laparoscopic myomectomy, J Obstet Gynaecol Res, 45, 176, 10.1111/jog.13808 Zhang, 2018, Analysis of the effect of laparoscopy and hysteroscopy on ovarian function, immune function and quality of sexual life of patients with hysteromyoma at different ages, Oncol Lett, 15, 2929 Radosa, 2016, Postoperative quality of life and sexual function in premenopausal women undergoing laparoscopic myomectomy for symptomatic fibroids: a prospective observational cohort study, PLOS ONE, 11, 10.1371/journal.pone.0166659 Dilek, 2010, The effect of myomectomy on health-related quality of life of women with myoma uteri, J Obstet Gynaecol Res, 36, 364, 10.1111/j.1447-0756.2009.01149.x Spies, 2010, Outcomes from leiomyoma therapies: comparison with normal controls, Obstet Gynecol, 116, 641, 10.1097/AOG.0b013e3181ed36b3 Ertunc, 2009, The effect of myoma uteri and myomectomy on sexual function, J Sex Med, 6, 1032 Mashiach, 2018, Outcome of magnetic resonance-guided focused ultrasound surgery (MRgFUS) for FIGO class 1 fibroids, Eur J Obstet Gynecol Reprod Biol, 221, 119, 10.1016/j.ejogrb.2017.12.025 Taran, 2009, Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas, Ultrasound Obstet Gynecol, 34, 572, 10.1002/uog.7435 Garza-Leal, 2019, Long-term clinical outcomes of transcervical radiofrequency ablation of uterine fibroids: the VITALITY study, J Gynecol Surg, 35, 19, 10.1089/gyn.2018.0051 He, 2018, A retrospective study of ultrasound-guided high intensity focused ultrasound ablation for multiple uterine fibroids in South Africa, Int J Hyperthermia, 34, 1304, 10.1080/02656736.2017.1421323 Hudgens, 2019, 12-month outcomes of the US patient cohort in the Sonata pivotal IDE trial of transcervical ablation of uterine fibroids, Int J Womens Health, 11, 387, 10.2147/IJWH.S201912 Ierardi, 2019, Percutaneous microwave ablation of uterine fibroids: correlation between shrinkage and trend symptoms, Minim Invasive Ther Allied Technol, 1, 10.1080/13645706.2019.1668417 Chudnoff, 2019, Ultrasound-guided transcervical ablation of uterine leiomyomas, Obstet Gynecol, 133, 13, 10.1097/AOG.0000000000003032 Brölmann, 2016, The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids, Gynecol Surg, 13, 27, 10.1007/s10397-015-0915-3 Berman, 2014, Three years’ outcome from the halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas, J Minim Invas Gynecol, 21 Mariara, 2017, One year symptom severity and health-related quality of life changes among black African patients undergoing uterine fibroid embolisation, BMC Res Notes, 10, 240, 10.1186/s13104-017-2558-0 Voogt, 2009, Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids, Fertil Steril, 92, 756, 10.1016/j.fertnstert.2008.06.007 Smith, 2004, Patient satisfaction and disease specific quality of life after uterine artery embolization, Am J Obstet Gynecol, 190, 1697, 10.1016/j.ajog.2004.02.043 Shveiky, 2013, The effect of uterine fibroid embolization on lower urinary tract symptoms, Int Urogynecol J, 24, 1341, 10.1007/s00192-012-2013-7 Spies, 1999, Uterine fibroid embolization: measurement of health-related quality of life before and after therapy, J Vasc Interv Radiol, 10, 1293, 10.1016/S1051-0443(99)70235-6 Spies, 2004, Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study, Am J Obstet Gynecol, 191, 22, 10.1016/j.ajog.2004.03.037 Liu, 2011, Prospective comparison of laparoscopic uterine artery occlusion plus myomectomy with classic intrafascial supracervical hysterectomy for symptomatic fibroid treatment: differences in post-operative quality-of-life measures, Eur J Obstet Gynecol Reprod Biol, 155, 79, 10.1016/j.ejogrb.2010.10.022 Chen, 2016, The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in china, J Ther Ultrasound, 4, 27, 10.1186/s40349-016-0072-9 Duvnjak, 2017, Assessment of uterine fibroid infarction after embolization with tris-acryl gelatin microspheres, Cogent Med, 4, 10.1080/2331205X.2017.1360543 Fornazari, 2019, Impact of uterine contractility on quality of life of women undergoing uterine fibroid embolization, CVIR Endovasc, 2, 36, 10.1186/s42155-019-0080-2 Guido, 2013, Radiofrequency volumetric thermal ablation of fibroids: a prospective, clinical analysis of two years’ outcome from the halt trial, Health Qual Life Outcomes, 11, 139, 10.1186/1477-7525-11-139 Keserci, 2017, Volumetric magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids through abdominal scars: the impact of a scar patch on therapeutic efficacy and adverse effects, J Ther Ultrasound, 5, 22, 10.1186/s40349-017-0100-4 Lee, 2010, Radiofrequency thermal ablation of submucosal leiomyoma: a preliminary report on health, symptom, and quality of life outcomes, J Gynecol Surg, 26, 227, 10.1089/gyn.2009.0101 Lin, 2009, Treatment of uterine fibroids by using magnetic resonance-guided focused ultrasound ablation: the initial experience in Taiwan, Chin. J Radiol, 34, 263 Turtulici, 2019, Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study, Int J Hyperthermia, 35, 97, 10.1080/02656736.2018.1479778 Spies, 2001, Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata, J Vasc Interv Radiol, 12, 1059, 10.1016/S1051-0443(07)61591-7 Spies, 2005, The FIBROID registry: symptom and quality-of-life status 1 year after therapy, Obstet Gynecol, 106, 1309, 10.1097/01.AOG.0000188386.53878.49 Neri, 2019, Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health, Gynecol Endocrinol, 35, 756, 10.1080/09513590.2019.1576618 Tuschy, 2018, Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids, Eur J Obstet Gynecol Reprod Biol, 228, 106, 10.1016/j.ejogrb.2018.06.027 Feng, 2010, Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone, Int J Gynecol Obstet, 109, 121, 10.1016/j.ijgo.2009.11.019 Murji, 2016, Role of ethnicity in treating uterine fibroids with ulipristal acetate, Fertil Steril, 106, 1165, 10.1016/j.fertnstert.2016.06.012 Alonso, 2004, Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQoLA) Project, Qual Life Res, 13, 283, 10.1023/B:QURE.0000018472.46236.05 Lee, 2012, Health-related quality of life in breast cancer patients with lymphedema who survived more than one year after surgery, J Breast Cancer, 15, 449, 10.4048/jbc.2012.15.4.449 Xu, 2017, Examining the health-related quality of life using EQ-5D-5L in patients with four kinds of chronic diseases from specialist outpatient clinics in Hong Kong SAR, China, Patient Prefer Adherence, 11, 1565, 10.2147/PPA.S143944 Yousefi, 2016, Comparison of SF-6D and EQ-5D scores in patients with breast cancer, Iran Red Crescent Med J, 18, e23556, 10.5812/ircmj.23556 Laughlin-Tommaso, 2019, FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery, Am J Obstet Gynecol, 220, 174.e1, 10.1016/j.ajog.2018.10.032 Derogatis, 1977, Confirmation of the dimensional structure of the scl-90: a study in construct validation, J Clin Psychol, 33, 981, 10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0 Hopwood, 2001, A body image scale for use with cancer patients, Eur J Cancer, 37, 189, 10.1016/S0959-8049(00)00353-1 Rosen, 2000, The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function, J Sex Marital Ther, 26, 191, 10.1080/009262300278597 Taylor, 1994, Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women, Arch Sex Behav, 23, 627, 10.1007/BF01541816 Rogers, 2003, A short form of the Pelvic Organ prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12), Int Urogynecol J, 14, 164, 10.1007/s00192-003-1063-2 Lubeck, 1999, A health related quality of life measure for use in patients with urge urinary incontinence: a validation study, Qual Life Res, 8, 337, 10.1023/A:1008974420049 Roovers, 2001, Does mode of hysterectomy influence micturition and defecation?, Acta Obstet Gynecol Scand, 80, 945, 10.1080/791200711 Stull, 2014, Validation of the SF-36 in patients with endometriosis, Qual Life Res, 23, 103, 10.1007/s11136-013-0442-5 Hayes, 2017, Reliability and Validity of the Medical Outcomes Study Short Form-12 Version 2 (SF-12v2) in adults with non-cancer pain, Healthcare Version 2, 5, 22 Aubry, 2017, Measuring health-related quality of life in women with endometriosis: comparing the clinimetric properties of the Endometriosis Health Profile-5 (EHP-5) and the EuroQol-5D (EQ-5D), Hum Reprod, 32, 1258, 10.1093/humrep/dex057 Sung, 2003, Construct validation of the Health Utilities Index and the Child Health Questionnaire in children undergoing cancer chemotherapy, Br J Cancer, 88, 1185, 10.1038/sj.bjc.6600895 Webster, 2010, Validation of the WHOQOL-bref among women following childbirth, Aus N Z J Obstet Gynaecol, 50, 132, 10.1111/j.1479-828X.2009.01131.x Derogatis, 1977, Confirmation of the dimensional structure of the scl-90: a study in construct validation, J Clin Psychol, 33, 981, 10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0 Rosen, 2000, The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function, J Sex Marital Ther, 26, 191, 10.1080/009262300278597 Taylor, 1994, Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women, Arch Sex Behav, 23, 627, 10.1007/BF01541816 Rogers, 2003, A short form of the Pelvic Organ prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12), Int Urogynecol J, 14, 164, 10.1007/s00192-003-1063-2 Vroege, 1996 Thirlaway, 1996, The Sexual Activity Questionnaire: A measure of women’s sexual functioning, Qual Life Res, 5, 81, 10.1007/BF00435972 Lubeck, 1999, A health related quality of life measure for use in patients with urge urinary incontinence: a validation study, Qual Life Res, 8, 337, 10.1023/A:1008974420049 Roovers, 2001, Does mode of hysterectomy influence micturition and defecation?, Acta Obstet Gynecol Scand, 80, 945, 10.1080/791200711 Hopwood, 2001, A body image scale for use with cancer patients, Eur J Cancer, 37, 189, 10.1016/S0959-8049(00)00353-1 Spies, 2002, The UFS-QoL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata, Obstet Gynecol, 99, 290